Visibly’s at-home tests take six minutes to complete and can be self-administered on a computer or mobile device.
The vision test results are sent to an eye-care specialist immediately, who can then make patient recommendations.
“After many years working with the FDA, we are excited to receive this clearance,” Brent Rasmussen, CEO of Visibly, said in the release. “We look forward to fulfilling our mission of bringing affordable, accessible vision care to the masses.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
